ArticleFrontiers in endocrinology2023
Apolipoprotein B and interleukin 1 receptor antagonist: reversing the risk of coronary heart disease.
Fangkun Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it